Beyond Covid 19 Vaccines: Our Top Five Scientific Achievements from 2021

December 27th, 2021 – From dancing molecules fixing spinal cord injuries to the large-scale production of antibiotics from CRISPR-edited bacteria, 2021 has provided reasons for hope during a depressing pandemic. Here, we describe our top 5 list from 2021 to remind us why we all do what we do.

No Obstacle Is Too Big: People Who Endure Tragedy Are Often The Most Unstoppable

November 4th, 2021 – Read our interview with the lung cancer activist and NFL legend Chris Draft. Learn why he thinks young scientists need to “dream bigger dreams.”


October 19th, 2021 – We sat down with this year’s Nobel Laureate for Physiology or Medicine, Dr. Ardem Patapoutian, to learn about his fascinating prize-winning breakthrough and how he faced challenges on the road to success.

Two Cancers: Progress and Challenges in light of the Immunotherapy Revolution

September 20th, 2021 – September is particularly significant to us here at Radyus, as it is cancer awareness month. We want to celebrate some major achievements and acknowledge ongoing frustration in two specific cancer types – lung cancer and glioblastoma.

Five Easy Ways to Enhance Your Negotiation Success

September 7th, 2021 – Learn how to improve your next negotiation – from small talk, to taking control of your emotions – it’s not as daunting as you might think.

'all that glitters is not gold' - what can Simone biles teach the biotech entrepreneur?

August 24th, 2021 – Whether you’re a fan or not, Simone Biles turned the sporting world on its head at this year’s Tokyo Olympics. Read about the personal and business benefits of following in her footsteps.

go get that government cash!

August 10th, 2021 – Welcome to the final stretch before the September 5th deadline! While your friends and family are still enjoying summer, you’re stuck inside writing this darn SBIR grant. We hear you. And we wanted to help. So, we gathered feedback from highly accomplished study section grant reviewers to get the inside scoop on the things that can get you dinged and the things that can make you shine in the eyes of your review committee.

What’s the single most important document on your drug development journey? A Target Product Profile (TPP)

July 25th, 2021 – You might wondering why? Well, everything starts with a product. You have a new technology, but is it a product yet? How is it better than the competition or standard of care? Is it more efficacious, safer, easier to administer, or less expensive to manufacture? Will the regulators approve it? Will someone buy it? Will doctors prescribe it? Will patients use it? Will investors invest in it?

Stop Herding Cats: 5 Reasons You Need a New CRO Approach

July 12th, 2021 – Your new biotech company is lean and virtual. So, you have to rely on an army of consultants and contract research organizations (CROs) to outsource your preclinical research. Managing them can often feel like herding cats. 

Pride Month: Lgbtq scientific breakthroughs

June 28th, 2021 – At Radyus Research, we understand the importance of recognizing individuals of all backgrounds. In honor of Pride Month, we explore three LGBTQ scientists who have influenced modern science. They continue to push the limits in their professional and private lives to contribute to the betterment of all the humanity. We call that bravery!

When is a CRO not a CRO?: When you are at a critical juncture in the development of your new therapy and your biotech start up needs the expert insights of a “Collaborative Research Organization”

June 14th, 2021 – The biotech field is crowded with all sorts of confusing jargon and acronyms, so you might be wondering – what exactly is a Collaborative Research Organization (a CRO) and how can it help my startup? And how is this different from a Contract Research Organization (also a CRO, and not to be confused with a Clinical Research Organization—also, also a CRO!). In this blog post, we break down the ins and outs of a Collaborative Research Organization and why your organization needs one to turn its drug development goals into a reality…

Successfully Transitioning from Academia to a Biotech Startup

May 31st, 2021 – At Radyus Research, we understand how difficult it may be to transition from academia to a biotech startup. There are both similarities and differences between work for an academic lab, and work for a biotech startup. Those who have worked in academia will have a deep understanding of moving a project forward despite low budgets, and convincing others of the importance of your work…

In the Spotlight: Interview with Alice Zhang – CEO and Co-Founder of Verge Genomics

May 17th, 2021 – Alice Zhang is challenging the status quo within the drug development industry as the CEO and co-founder of Verge Genomics. At just over 30 years old, she is leading a San Francisco based team of nerdy PhDs and experienced drug developers, as they seek to reinvigorate the field of neurodegenerative diseases…


May 3rd, 2021 – At Radyus Research, we understand the importance that individuals of all backgrounds contribute to biotechnology and other scientific fields of study. Whether through research, preclinical trials, or breakthrough discoveries, the hard work and dedication of Asian American and Pacific Islander (AAPI) scientists has had a lasting impact on the scientific community…

First-Time CEOs in Biotech - The Path To Success

April 19th, 2021 – At Radyus Research, we are committed to supporting first-time CEOs and company founders in biotech in their paths to success. Becoming a first-time CEO can be incredibly exciting but can also be quite a daunting task…

Diversity Month: Celebrating Diverse leaders in STEM

April 5th, 2021 – At Radyus Research, we work with many innovators across STEM (science, technology, engineering, and mathematics) fields looking to achieve their drug and business development goals…


March 29, 2021 – In celebration of Women’s History Month, Radyus Research has added renowned oncology researcher and entrepreneur Dr. Laura Soucek to its scientific advisory board…

Creative Strategies Women are Using to Close the Fundraising Gap

March 23, 2021 – Over the years, both women and men have brought new products and services to the entrepreneurial table. However, it is important to address that women have faced an uphill battle in their path to venture creation…

Radyus Research adds Dr. Mark Shlomchik to Scientific Advisory Board

March 15, 2021 – Fueling its efforts to accelerate the drug development process, Radyus Research is pleased to announce the addition of Dr. Mark Shlomchik to its scientific advisory board…

International Women’s Day: Notable Women in Science

March 8, 2021 – Many of the most important discoveries within the field of science have been achieved by accomplished women across several time periods. Despite the social obstacles they faced, these women were able to overcome significant challenges and put forth groundbreaking research that fundamentally changed the way we understand a wide variety of scientific fields of study. In honor of International Women’s Day, we explore the achievements of a few of these notable women in the field of science…

New Angle on Early-Stage Financing for Biotech Startups: Tell a Better Story

March 1, 2021 – Without seed funding, it is seemingly impossible to commercialize a breakthrough scientific discovery. Given the complexities of navigating the venture capital markets, it is no surprise that many scientific co-founders commonly find themselves agreeing to sub-optimal financing terms that are unscrupulously obstructive. Biotech entrepreneurs can avoid unnecessary dilution, preserve operational control, and minimize financing costs by aligning their product strategy with deliberate go-to-market, growth, and exit plans…

Black History Month: African American Breakthroughs in Medicine

February 15, 2021 – Over the years, we have seen many breakthroughs in the field of medicine. Many of these important advances were accomplished by African Americans who were able to successfully change the medical field for the betterment of our society, in spite of the significant challenges they faced. In honor of Black History Month, we explore four African American medical pioneers who broke racial barriers to help advance the field of medicine…

Radyus Research taps Richard Silverman as Scientific Advisory Board member

January 19, 2021 – Richard B. Silverman, the Patrick G. Ryan/ Aon Professor in the departments of chemistry, molecular biosciences, and pharmacology at Northwestern University, and the inventor of Pfizer’s blockbuster Lyrica drug, has joined Radyus Research’s scientific advisory board…

Radyus Research making waves in Atlanta biotech community

October 6, 2020 – An emerging company in the Atlanta scientific community is leading the charge to improve the drug development process to help accelerate biotech companies working to bring life-saving solutions to market…

Scroll to Top